The patients with high KDR, PDGFRA, LRP1, COL1A2, and SAMD9 expression had shorter OS (Figure 2C-G) (log-rank test, P < 0.05), indicating that tumor antigens were critical for the progression of diffuse gliomas. The gene discussed is SAMD9; the disease is neoplasm.